ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Roberto A. Calle, Neeta B. Amin, Santos Carvajal‐Gonzalez, Trenton T. Ross, Arthur Bergman, Sudeepta Aggarwal, Collin Crowley, Anthony Rinaldi, Jessica Mancuso, Naresh Aggarwal, Veena Somayaji, Małgorzata Inglot, Theresa Tuthill, Kou Kou, Magalie Boucher, Greg Tesz, Robert Dullea, Kendra K. Bence, Albert M. Kim, Jeffrey A. Pfefferkorn, William P. Esler